[go: up one dir, main page]

AR108992A1 - Formulaciones líquidas estabilizadas que contienen picosulfato - Google Patents

Formulaciones líquidas estabilizadas que contienen picosulfato

Info

Publication number
AR108992A1
AR108992A1 ARP170101886A ARP170101886A AR108992A1 AR 108992 A1 AR108992 A1 AR 108992A1 AR P170101886 A ARP170101886 A AR P170101886A AR P170101886 A ARP170101886 A AR P170101886A AR 108992 A1 AR108992 A1 AR 108992A1
Authority
AR
Argentina
Prior art keywords
picosulfate
sodium
formulations containing
liquid formulations
liquid formulation
Prior art date
Application number
ARP170101886A
Other languages
English (en)
Inventor
Nipul Ghanshyambhai Patel
Alfred Chi-Yeh Liang
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of AR108992A1 publication Critical patent/AR108992A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Una formulación líquida que comprende: picosulfato; citrato de magnesio y un antioxidante. Reivindicación 2: La formulación líquida de la reivindicación 1, en donde el picosulfato es picosulfato de sodio. Reivindicación 5: La formulación líquida de cualquiera de las reivindicaciones 1 a 4, en donde el antioxidante se selecciona entre ácido ascórbico o una sal o un éster del mismo, hidroxianisol butilado, hidroxitolueno butilado, histidina, D-manosa, ácido propiónico, metabisulfito de potasio, galato de propilo, metabisulfito de sodio, sulfito de sodio, tiosulfato de sodio, dióxido de azufre y a-tocoferol.
ARP170101886A 2016-07-08 2017-07-07 Formulaciones líquidas estabilizadas que contienen picosulfato AR108992A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662360188P 2016-07-08 2016-07-08

Publications (1)

Publication Number Publication Date
AR108992A1 true AR108992A1 (es) 2018-10-17

Family

ID=59523223

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170101886A AR108992A1 (es) 2016-07-08 2017-07-07 Formulaciones líquidas estabilizadas que contienen picosulfato

Country Status (4)

Country Link
US (3) US20180015078A1 (es)
AR (1) AR108992A1 (es)
TW (1) TW201804996A (es)
WO (1) WO2018009761A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
RU2018105869A (ru) 2015-08-17 2019-09-19 Ферринг Б.В. Жидкие составы, содержащие пикосульфат и цитрат магния
AR108992A1 (es) 2016-07-08 2018-10-17 Ferring Bv Formulaciones líquidas estabilizadas que contienen picosulfato
US20240325436A1 (en) * 2021-06-17 2024-10-03 Braintree Laboratories, Inc. Safe Flavoring Composition to Improve Compliance in Colon Cleansing Compositions
CN116585261B (zh) * 2023-05-17 2024-05-14 深圳市贝美药业有限公司 药物液体组合物及其制备方法和应用
WO2025093697A1 (en) 2023-11-03 2025-05-08 Casen Recordati S.L. Ready-to-use laxative liquid pharmaceutical composition and process for its preparation
CN117338709B (zh) * 2023-11-07 2025-08-22 浙江和沐康医药科技有限公司 一种复方匹可硫酸钠口服溶液及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697248A (en) 1979-12-28 1981-08-05 Tanaka Shiro Conjugated compound of calcium citrate and calcium malate and its preparation
US5010069A (en) * 1989-05-15 1991-04-23 Marion Laboratories, Inc. Stable liquid form of 5-aminosalicylic acid
FR2647347A1 (fr) 1989-05-24 1990-11-30 Lucien Laboratoires Agents et complexes de l'ion mg2+ facilitant l'absorption du magnesium dans un organisme humain ou animal, et compositions pharmaceutiques ou dietetiques utilisables pour l'administration de magnesium dans un organisme humain ou animal
JP2557111B2 (ja) 1989-11-27 1996-11-27 フジックス 株式会社 高濃度のマグネシウム溶液の製造方法及びそれによって得られたマグネシウム溶液並びにその用途
CA2085008C (en) 1990-06-14 1998-08-18 Mary M. Fox Calcium citrate malate composition
WO1992007475A1 (en) 1990-10-31 1992-05-14 The Procter & Gamble Company Calcium fortified sauces
JP2930737B2 (ja) 1990-12-27 1999-08-03 雪印乳業株式会社 カルシウム強化食品およびその製造方法
US5498425A (en) 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative
JPH10327805A (ja) 1997-06-02 1998-12-15 Yasuma Kk マグネシウム含有食品組成物
JPH11299454A (ja) 1998-04-27 1999-11-02 Sankyo Foods Kk ドロマイトの可溶化方法
WO2001066083A1 (fr) 2000-03-10 2001-09-13 Taisho Pharmaceutical Co., Ltd. Preparations de gels destinees a une administration par voie orale a proprietes de conservation ameliorees
JP4245821B2 (ja) 2000-04-28 2009-04-02 協和発酵バイオ株式会社 カルシウムおよびマグネシウム溶液及びそれを含有する飲食品並びにそれらの製造方法
GB0224909D0 (en) 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
HUE038174T2 (hu) 2007-10-12 2018-09-28 Ferring Int Center Sa Eljárás citromsavat, magnéziumoxidot, káliumbikarbonátot és nátriumpikoszulfátot tartalmazó gyógyszertermék elõállítására, ilyen eljárással elõállított szemcsés gyógyászati készítmény és köztitermékei
EP2515858A1 (en) 2009-12-25 2012-10-31 Mahmut Bilgic Pharmaceutical composition with high purity
EP2568959A2 (en) 2010-05-14 2013-03-20 Mahmut Bilgic Formulations comprising a third generation cephalosporin and clavulanic acid
WO2012102799A2 (en) 2011-01-28 2012-08-02 Shaver William A Method, composition and package for bowel cleansing
AU2012284200B2 (en) 2011-07-15 2016-09-22 Ferring B.V. Method for timing a colonoscopy wherein a picosulate composition is administered
US9238075B2 (en) 2011-12-07 2016-01-19 Msm Innovations, Inc. Method for bowel preparation
KR101155099B1 (ko) 2012-03-29 2012-06-11 남봉길 장 세척용 조성물의 제조 방법 및 이에 의해 제조된 장 세척용 조성물
ES2717282T3 (es) * 2012-07-27 2019-06-20 Redhill Biopharma Ltd Formulaciones y métodos para fabricar formulaciones para su uso en la evacuación colónica
BR112015004165A2 (pt) 2012-08-29 2017-07-04 Salix Pharmaceuticals Inc métodos e composições laxantes para o tratamento de constipação e condições e doenças gastrointestinais relacionadas
KR101517520B1 (ko) 2013-08-05 2015-05-04 이희엽 피코황산나트륨 함유 장 세척용 조성물의 제조방법
IN2013MU02911A (es) 2013-09-10 2015-07-03 Cadila Healthcare Ltd
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
RU2018105869A (ru) 2015-08-17 2019-09-19 Ферринг Б.В. Жидкие составы, содержащие пикосульфат и цитрат магния
AR108992A1 (es) 2016-07-08 2018-10-17 Ferring Bv Formulaciones líquidas estabilizadas que contienen picosulfato

Also Published As

Publication number Publication date
TW201804996A (zh) 2018-02-16
US20220370427A1 (en) 2022-11-24
WO2018009761A1 (en) 2018-01-11
US20180015078A1 (en) 2018-01-18
US20260014128A1 (en) 2026-01-15
US12458634B2 (en) 2025-11-04

Similar Documents

Publication Publication Date Title
AR108992A1 (es) Formulaciones líquidas estabilizadas que contienen picosulfato
MX2017016819A (es) Composiciones antimicrobianas y sus usos.
CL2019000586A1 (es) Composiciones de toxinas clostridiales no proteicas.
MX387604B (es) Formulaciones cannabinoides estables.
MX2018006503A (es) Compuesto novedoso de bifenilo o una sal del mismo.
EP3600563C0 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING VITAMIN D3 AND HYALURONIC ACID
AR102198A1 (es) Proceso para reducir partículas subvisibles en una formulación farmacéutica
MX2023001963A (es) Composiciones farmaceuticas hipertonicas que contienen un agente quimioprotector antiplatino.
MX2019014104A (es) Compuesto novedoso de bifenilo o sal del mismo.
AR097067A1 (es) Formulación que comprende un agente hipolipidémico
BR112015027537A2 (pt) uso do ácido graxo de resina líquida
MX2019002880A (es) Proceso para elaborar una composicion que comprende particulas de suministro de agente benefico.
ECSP14026432A (es) (r)-nifuratel y síntesis de (r) y (s)-nifuratel
AR096338A1 (es) (ciano-dimetil-metil)-isoxazoles y -[1,3,4]tiadiazoles
AR101581A1 (es) Composición de colutorio
MX2018007865A (es) Composiciones para el cuidado personal.
CL2017000244A1 (es) Formulaciones de compuestos biológicos para instilación intravesical.
AR102780A1 (es) Composiciones farmacéuticas, su preparación y sus usos
AR096704A1 (es) Formulación detergente higroscópica que comprende agua, agente quelante aminocarboxilato e ingredientes sensibles a la humedad
CL2019002516A1 (es) Composiciones cosméticas para el cuidado de la piel.
BR112018015095A2 (pt) recipiente de material de construção
MX382596B (es) Composiciones que contienen arsénico y su uso en métodos de tratamiento.
AR094572A1 (es) Composiciones herbicidas que comprenden ácido 4-amino-3-cloro-6-(4-cloro-2-fluoro-3-metoxifenil)piridin-2-carboxílico o uno de sus derivados y picloram o uno de sus derivados
CL2018003110A1 (es) Preparación y dispersión de formulaciones de emulsión estable.
AR090564A1 (es) Co-cristales de dicamba y un formador co-cristal b

Legal Events

Date Code Title Description
FB Suspension of granting procedure